New: Introducing the Finviz Crypto Map

BriaCell Therapeutics Corp.

Contributing Author

Recent Articles by BriaCell Therapeutics Corp.

Jul-16	BriaCell Therapeutics Announces Closing of $15 million Public Offering BCTX GlobeNewswire
Jul-15	BriaCell Therapeutics Announces Pricing of $15 million Public Offering BCTX GlobeNewswire
Jul-15	BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer BCTX GlobeNewswire
Jul-11	BriaCell's Bria-IMT Demonstrates Survival Advantage over Trodelvy and Control Group in Metastatic Breast Cancer BCTX GlobeNewswire
Jul-10	BriaCell Reports Complete and Sustained Resolution of Brain Metastasis and Sustained Regression of Orbital Metastasis in "Eye-Bulging" Breast Cancer Patient BCTX GlobeNewswire
Jul-09	BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS Metastatic Breast Cancer Study BCTX GlobeNewswire
Jul-08	BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer BCTX GlobeNewswire
Jul-02	BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven BCTX GlobeNewswire
Jun-24	BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer BCTX GlobeNewswire
Jun-04	BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 BCTX GlobeNewswire
Jun-02	BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 BCTX GlobeNewswire
May-27	BriaCell Bria-OTS Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor BCTX GlobeNewswire
May-23	BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 BCTX GlobeNewswire
May-20	BriaCell CEO Letter to Shareholders BCTX GlobeNewswire

Affiliate • Advertise • Theme Settings • Contact • Blog • Help • Privacy • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.